Kadmon Corporation, LLC

UEI
EZRWFE9KAEF6
CAGE
6ALL0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
Corporate family
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Discovery of inhibitors of the metabolic oncogene 3-phosphoglycerate dehydrogenas R43CA176897 National Institutes of Health $172,052
Treatment of cytomegalovirus by inhibition of host lipid synthesis R43AI098206 National Institutes of Health $184,624

Quick answers

Is Kadmon Corporation, LLC registered in SAM.gov?

Kadmon Corporation, LLC's SAM.gov registration expired on July 7, 2022.

What is Kadmon Corporation, LLC's most recent federal award?

Kadmon Corporation, LLC's most recent federal grant award is Discovery of inhibitors of the metabolic oncogene 3-phosphoglycerate dehydrogenas (R43CA176897), from National Institutes of Health, on August 11, 2014.

On GovTribe

See Kadmon Corporation, LLC's full federal record

  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login